85 related articles for article (PubMed ID: 18159997)
1. L-arginine reverses alterations in drug disposition induced by spinal cord injury by increasing hepatic blood flow.
Vertiz-Hernandez A; Castaneda-Hernandez G; Martinez-Cruz A; Cruz-Antonio L; Grijalva I; Guizar-Sahagun G
J Neurotrauma; 2007 Dec; 24(12):1855-62. PubMed ID: 18159997
[TBL] [Abstract][Full Text] [Related]
2. Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism.
Cruz-Antonio L; Flores-Murrieta FJ; García-Löpez P; Guízar-Sahagún G; Castañeda-Hernández G
J Neurotrauma; 2006 Jan; 23(1):75-85. PubMed ID: 16430374
[TBL] [Abstract][Full Text] [Related]
3. Systemic microcirculation after complete high and low thoracic spinal cord section in rats.
Guízar-Sahagún G; Velasco-Hernández L; Martínez-Cruz A; Castañeda-Hernández G; Bravo G; Rojas G; Hong E
J Neurotrauma; 2004 Nov; 21(11):1614-23. PubMed ID: 15684653
[TBL] [Abstract][Full Text] [Related]
4. Alteration of phenacetin pharmacokinetics after experimental spinal cord injury.
Cruz L; Castañeda-Hernández G; Flores-Murrieta FJ; García-López P; Guízar-Sahagún G
Proc West Pharmacol Soc; 2002; 45():4-5. PubMed ID: 12434508
[No Abstract] [Full Text] [Related]
5. Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously.
García-López P; Martínez-Cruz A; Guízar-Sahagún G; Castañeda-Hernández G
Spinal Cord; 2007 Sep; 45(9):603-8. PubMed ID: 17179977
[TBL] [Abstract][Full Text] [Related]
6. Early administration of L-arginine in experimental acute spinal cord injury impairs long-term motor function recovery.
Esquivel-Aguilar A; Castañeda-Hernández G; Martínez-Cruz A; Franco-Bourland RE; Madrazo I; Guízar-Sahagún G
J Trauma; 2011 May; 70(5):1198-202. PubMed ID: 20693923
[TBL] [Abstract][Full Text] [Related]
7. The effect of consecutively larger doses of L-arginine on hepatic microcirculation and tissue oxygenation in hepatic steatosis.
Ijaz S; Winslet MC; Seifalian AM
Microvasc Res; 2009 Sep; 78(2):206-11. PubMed ID: 19573538
[TBL] [Abstract][Full Text] [Related]
8. Protection against hepatic ischemia/reperfusion injury by exogenous L-arginine.
Shiraishi M; Kusano T; Aihara T; Ikeda Y; Koyama Y; Muto Y
Transplant Proc; 1996 Jun; 28(3):1887-8. PubMed ID: 8658931
[No Abstract] [Full Text] [Related]
9. Contrasting effects of cord injury on intravenous and oral pharmacokinetics of diclofenac: a drug with intermediate hepatic extraction.
Cruz-Antonio L; Arauz J; Franco-Bourland RE; Guízar-Sahagún G; Castañeda-Hernández G
Spinal Cord; 2012 Aug; 50(8):632-5. PubMed ID: 22410846
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
Hepatology; ; . PubMed ID: 9462634
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
